Clinical Trials Sponsored by Nasser Hanna

Total 1305 results

Nasser Hanna

Completed

Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors

Testis Cancer | Testicular Cancer | Germ Cell Tumor

United States
Nasser Hanna

Completed

Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late Relapse

Neoplasms, Germ Cell and Embryonal

United States
Nasser Hanna
Genentech, Inc.

Terminated

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

NSCLC Stage IV | NSCLC, Recurrent

United States
Nasser Hanna
Genentech, Inc.

Recruiting

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

NSCLC | Lung Cancer

United States
Nasser Hanna, M.D.
Bristol-Myers Squibb; Hoosier Cancer Research Network

Terminated

Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor

Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

United States
Nasser Hanna, M.D.
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Completed

Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC

Carcinoma, Non-Small-Cell Lung

United States
Nasser Hanna, M.D.
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Terminated

Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors

Genital Neoplasms, Female | Testicular Neoplasms | Genital Neoplasms, Male | Ovarian Neoplasms | Mediastinal Neoplasms | Germ Cell Neoplasms | Non Seminomatous Germ Cell Tumors

United States
Nasser Hanna, M.D.
Sanofi; Walther Cancer Institute

Completed

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Nasser Hanna, M.D.
Bayer; Amgen; Walther Cancer Institute

Terminated

Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Nasser Hanna, M.D.
Genentech, Inc.; Hoosier Cancer Research Network; Walther Cancer Institute

Completed

Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer

Lung Cancer

United States
Nasser Hanna, M.D.
Bristol-Myers Squibb; Walther Cancer Institute

Completed

Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

Esophageal Cancer

United States
Hanna Jangö

Completed

Translation and Validation of the ICIQ-B in Danish

Quality of Life | Pelvic Floor Disorders | Anal Incontinence | Anal Sphincter Tear

Denmark
Nasser Hanna, M.D.
Bristol-Myers Squibb; Eli Lilly and Company; Walther Cancer Institute

Completed

Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Hanna van Eijsden

Not yet recruiting

Vibrotactile Feedback Belt in Patients With Unilateral Vestibular Hypofunction (UVH) (VIBE)

Vestibular Disorder

Netherlands
Hanna Holmberg
University of Salford

Completed

Isometric Core Muscle Endurance in Healthy Active and Non-active Working Age Populations

Physical Endurance

United Kingdom
Hansa Biopharma AB

Recruiting

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children (DINKY)

Kidney Transplantation in Highly Sensitized Patients

Spain, Finland, Sweden
Hansa Biopharma AB

Recruiting

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys (ConfIdeSLTFU)

Kidney Transplantation in Highly Sensitized Patients

United States
Hansa Biopharma AB

Recruiting

A Study With Imlifidase in Anti-GBM Disease (GOOD-IDES-02)

Anti-Glomerular Basement Membrane Disease | Goodpasture Syndrome | Anti-Glomerular Basement Membrane Antibody Disease | Good Pasture Syndrome

United States, Netherlands, Spain, Sweden, United Kingdom, Czechia, Germany, Italy, France, Denmark
Hansa Biopharma AB

Recruiting

Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx (ConfIdeS)

Kidney Transplantation in Highly Sensitized Patients

United States
Hansa Biopharma AB

Completed

Safety Study on IdeS in Healthy Volounteers

Healthy

Sweden
Hansa Biopharma AB

Completed

A Study of Imlifidase in Patients With Guillain-Barré Syndrome

Guillain-Barré Syndrome (GBS)

France, Netherlands, United Kingdom
Hansa Biopharma AB

Completed

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Kidney Transplant Failure and Rejection

United States, Sweden, France
Hansa Biopharma AB

Completed

Phase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease

Chronic Kidney Disease

Sweden
Hansa Biopharma AB

Recruiting

A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group (PAES-LTFU)

Long Term Efficacy and Safety

Spain, Czechia
Hansa Biopharma AB

Recruiting

Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts (PAES)

Kidney Transplantation in Highly Sensitized Patients

Spain, Italy, France, Netherlands, Belgium, Austria, Czechia, Sweden, United Kingdom, Slovenia
Hansa Biopharma AB

Completed

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Kidney Transplant Rejection

Australia, United States, Germany, France, Austria
Hansa Biopharma AB

Active, not recruiting

A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

Kidney Transplantation in Highly Sensitized Patients

United States
Hansa Biopharma AB

Terminated

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

Kidney Transplant Rejection

Germany, France, Austria
Hansa Biopharma AB

Completed

A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test (Highdes)

Kidney Failure, Chronic

United States, Sweden, France
Hanna Jangö
Region Hovedstadens Apotek

Recruiting

Oral Antibiotics After Obstetric Perineal Tear (REPAIR)

Infections | Wound Dehiscence | Obstetric Trauma

Denmark
Sylvia Maher Mohsen Farid Hanna

Not yet recruiting

The Effect of Manual Lymphatic Drainage on Acute and Post-acute Ankle Sprain in Athletes

Ankle Sprains
St. Anna Kinderkrebsforschung

Recruiting

High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)

Neuroblastoma

Norway, Czechia, United Kingdom, France, Spain, Belgium, Switzerland, Hungary, Israel, Australia, Italy, Austria, Denmark, Greece, Ireland, Poland, Portugal, Slovakia, Slovenia, Sweden
St. Anna Kinderkrebsforschung

Completed

Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections (FUNGITECT)

Systemic Mycosis

Austria, Netherlands, Russian Federation
St. Anna Kinderkrebsforschung

Withdrawn

Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation (VISIT)

Cytomegalovirus Infection | Adenovirus Infection

Austria
S. Anna Hospital

Unknown

Ultrasound Evaluation of the Jugular Venous Pulse (US-JVP) (US-JVP)

Cardiovascular Diseases | Emergencies | Neurovascular Disorders

Italy
St. Anna Kinderkrebsforschung

Completed

COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS) (INPOSIS)

Covid19 | SARS-CoV-2 Infection | Intestinal Infection

Austria
S. Anna Hospital

Unknown

Tap Block and Cesarean Delivery: Efficacy and Consumption of Postoperative Drugs (TAPFANS)

Cesarean Delivery

Italy
S. Anna Hospital

Completed

Safety of High-dose Tirofiban During Coronary Angioplasty (SANTISS)

Coronary Artery Disease

Italy
St. Anna Kinderkrebsforschung

Completed

Allogeneic Stem Cell Transplantation for Children With CML

Chronic Myeloid Leukemia

Austria, Czechia, Italy
St. Anna Kinderkrebsforschung

Unknown

ALL-SCT BFM International- HSCT in Children and Adolescents With ALL (ALL-SCT-BFMi)

Lymphoblastic Leukemia, Acute, Childhood;

Israel, Austria, Czech Republic, Denmark, France, Italy, Netherlands, Poland, Slovakia, Sweden, Turkey
Hannah Antony

Not yet recruiting

Home-based Treatment Using the Sidekick Tool for Pain Relief in Patients With Iliotibial Band Syndrome

Iliotibial Band Syndrome
hanaa mohsen

Completed

Effect of Platform Swing Walkway on Locomotor Behavior in Diplegic Children

Vestibular Rehabilitation

Egypt
Hanan Nabil

Completed

Preemptive Analgesia for Primary Dysmenorrhoea

Primary Dysmenorrhea

Egypt
hanaa mohsen

Completed

Effect of Core Stability Exercises on Hand Functions in Children With Hemiparesis

Cerebral Palsy

Egypt
Ellianne M. Nasser

Recruiting

Subchondroplasty for Treatment of Bone Marrow Edema in the Foot and Ankle

Bone Marrow Edema

United States
Hanna Kahila
Helsinki University Central Hospital; Lastentautien tutkimussäätiö

Not yet recruiting

Alcohol Use During Pregnancy in Finland According to Meconium Samples (RASMEK21)

Fetal Alcohol Spectrum Disorders
Alshimaa Nasser Mahmoud

Completed

Temperature Change of the Pulpal Floor and Restoration With Preheated Resin Composite (A Randomized Clinical Trial)

Preheating of Resin Composite

Egypt
Anna Martling

Active, not recruiting

Circulating Tumour DNA (ctDNA) as a Prognostic and Predictive Marker in Colorectal Cancer - a Pilot Study (CITCCA)

Colorectal Cancer

Sweden, Norway
Anna Sprinchorn

Active, not recruiting

Effects on Patient Satisfaction and Gait After Loss of Peroneus Longus Function

Patient Satisfaction | Gait, Rigid

Sweden
St. Anna Clinic Luzern

Completed

Lumbar Spine Surgery: Regional vs. General Anaesthesia

Herniated Disk Lumbar

Switzerland

Clinical Trials Sponsored by Nasser Hanna

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations